Compugen (CGEN) Tops Q1 EPS by 4c

Compugen (NASDAQ: CGEN) reported Q1 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $496 thousand versus the consensus estimate of $150 thousand.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress